Skip to contentB
Bioadaptives, Inc.
B
BDPTBioadaptives, Inc. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.98K$3.98Kderived+3.5% vs Q4 2021 Net Income-$28.28K-$28.28Kderivedno prior Q4 2021 on file EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bioadaptives, Inc. · CIK 1575142 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,030−9.8% Operating Cash Flowderived-$27,504N/M Margins · derivedGross margin25.9%−3.8 pt vs Q4 2021
Net margin-709.8%
ended Dec 31, 2022 · filed Mar 31, 2023 · 90 d after period end